Be a part of the first-ever national grassroots movement to change asthma care in the U.S. Join a network of families, healthcare providers, legislators and others who share the mission to end asthma deaths and suffering, starting today. From healthy living guidance to patient education and community involvement – the Great American Asthma Challenge touches all facets of asthma care. Everyone has a role to play. Read the rest of this entry »

Allergy & Asthma Network Mothers of Asthmatics (AANMA) to Launch
the Great American Asthma Challenge
First-Ever National Grassroots Movement to End Asthma Deaths in the United States

WASHINGTON, DC, APRIL 28, 2010 – Every day 10 people die from asthma. Most healthcare providers agree that these deaths are preventable. Patient education, access to care and a healthy lifestyle are proven methods that lead to less severe asthma symptoms, fewer hospitalizations and emergency department visits, fewer missed days of school and work – and fewer deaths. Read the rest of this entry »

On May 5, 2010, AANMA will unveil the Great American Asthma Challenge, the FIRST EVER national GRASSROOTS campaign destined to forever change asthma care in America! Read the rest of this entry »

Nancy Sander, founder and president of AANMA, testified during the Food and Drug Administration (FDA)’s open public hearing segment of the March 10-11 meeting of the Joint Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee. Read the rest of this entry »

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is seeking public comment on a draft of Guidelines for the Diagnosis and Management of Food Allergy. The public comment period is open until May 3. Health care professionals and interested members of the public are encouraged to review the guidelines and participate in the open comment period by visiting the NIAID Food Allergy Clinical Guidelines public comment site at www.niaid.nih.gov/topics/foodAllergy/clinical/comments.htm. Read the rest of this entry »

Allergy & Asthma Network Mothers of Asthmatics (AANMA) encourages patients to make informed decisions about recent U.S. Food and Drug Administration (FDA) recommendations affecting patients using asthma medications known as long-acting beta agonists (LABAs) or 12-hour bronchodilators: Advair, Foradil, Serevent and Symbicort.

This was also the message presented by allergists speaking this week at the American Academy of Allergy, Asthma and Immunology (AAAAI) annual meeting in New Orleans. Allergists are concerned that FDA’s recommendations are not consistent with Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma (EPR3) or with significant clinical practice in real-world settings. Furthermore, experts stated that FDA may have given more credence to some research that EPR3 authors considered unsupported by evidence. Read the rest of this entry »

AANMA hails South Dakota lawmakers for making it the 50th and final state in America to establish laws protecting students’ rights to carry and self-administer their lifesaving asthma medication at school.

South Dakota’s law also enables children with anaphylaxis to carry and use auto-injectable epinephrine, making it the 45th state to protect students’ rights to carry and use anaphylaxis medication at school. Five states — Mississippi, New York, Pennsylvania, Rhode Island and Wisconsin — remain without laws allowing students to carry and self-administer anaphylaxis medication. Read the rest of this entry »

Connecticut Gov. M. Jodi Rell recently met with parents, children and advocates who were instrumental in getting legislation passed in Connecticut that protects students’ rights to carry and self-administer lifesaving asthma and anaphylaxis medications at school. Read the rest of this entry »

Among the many tributes to Sen. Ted Kennedy, AANMA would like to acknowledge his friendship and support of our organization, especially over the past 12 years.

The Senator and his staff had a refreshingly down-to-earth approach when it came to addressing our concerns about ensuring patient access to specialty care, appropriate medications, immunotherapy and diagnostic services. They were always responsive in our efforts to make sure that all patients with these conditions have access to the care they need. Read the rest of this entry »